Literature DB >> 8332498

Termination of translation in bacteria may be modulated via specific interaction between peptide chain release factor 2 and the last peptidyl-tRNA(Ser/Phe).

A L Arkov1, S V Korolev, L L Kisselev.   

Abstract

The 5' context of 671 Escherichia coli stop codons UGA and UAA has been compared with the context of stop-like codons (UAC, UAU and CAA for UAA; UGG, UGC, UGU and CGA for UGA). We have observed highly significant deviations from the expected nucleotide distribution: adenine is over-represented whereas pyrimidines are under-represented in position -2 upstream from UAA. Uridine is over-represented in position -3 upstream from UGA. Lysine codons are preferable immediately prior to UAA. A complete set of codons for serine and the phenylalanine UUC codon are preferable immediately 5' to UGA. This non-random codon distribution before stop codons could be considered as a molecular device for modulation of translation termination. We have found that certain fragment of E. coli release factor 2 (RF2) (amino acids 93-114) is similar to the amino acid sequences of seryl-tRNA synthetase (positions 10-19 and 80-93) and of beta (small) subunit (positions 72-94) of phenylalanyl-tRNA synthetase from E. coli. Three-dimensional structure of E. coli seryl-tRNA synthetase is known [1]: Its N-terminus represents an antiparallel alpha-helical coiled-coil domain and contains a region homologous to RF2. On the basis of the above-mentioned results we assume that a specific interaction between RF2 and the last peptidyl-tRNA(Ser/Phe) occurs during polypeptide chain termination in prokaryotic ribosomes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8332498      PMCID: PMC309676          DOI: 10.1093/nar/21.12.2891

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  43 in total

1.  Nonrandom utilization of codon pairs in Escherichia coli.

Authors:  G A Gutman; G W Hatfield
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

2.  "Two out of three": an alternative method for codon reading.

Authors:  U Lagerkvist
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

Review 3.  Prediction of the secondary structure of proteins from their amino acid sequence.

Authors:  P Y Chou; G D Fasman
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1978

4.  Coding properties of an ochre-suppressing derivative of Escherichia coli tRNAITyr.

Authors:  S I Feinstein; S Altman
Journal:  J Mol Biol       Date:  1977-05-25       Impact factor: 5.469

5.  Translation of the UGA triplet in vitro by tryptophan transfer RNA's.

Authors:  D Hirsh; L Gold
Journal:  J Mol Biol       Date:  1971-06-14       Impact factor: 5.469

6.  The influence of the reading context upon the suppression of nonsense codons.

Authors:  W Salser
Journal:  Mol Gen Genet       Date:  1969-10-13

7.  Adjacent effect on suppression efficiency. II. Study on ochre and amber mutants of T4 phage lysozyme.

Authors:  H Yahata; Y Ocada; A Tsugita
Journal:  Mol Gen Genet       Date:  1970

8.  Codon-acticodon recognition in the valine codon family.

Authors:  S K Mitra; F Lustig; B Akesson; U Lagerkvist
Journal:  J Biol Chem       Date:  1977-01-25       Impact factor: 5.157

9.  Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.

Authors:  J Garnier; D J Osguthorpe; B Robson
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

10.  The influence of codon context on genetic code translation.

Authors:  L Bossi; J R Roth
Journal:  Nature       Date:  1980-07-10       Impact factor: 49.962

View more
  13 in total

1.  Does disparate occurrence of autoregulatory programmed frameshifting in decoding the release factor 2 gene reflect an ancient origin with loss in independent lineages?

Authors:  B C Persson; J F Atkins
Journal:  J Bacteriol       Date:  1998-07       Impact factor: 3.490

2.  Prokaryotic ribosomes recode the HIV-1 gag-pol-1 frameshift sequence by an E/P site post-translocation simultaneous slippage mechanism.

Authors:  J A Horsfield; D N Wilson; S A Mannering; F M Adamski; W P Tate
Journal:  Nucleic Acids Res       Date:  1995-05-11       Impact factor: 16.971

3.  Mutations to nonsense codons in human genetic disease: implications for gene therapy by nonsense suppressor tRNAs.

Authors:  J Atkinson; R Martin
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

4.  Is the in-frame termination signal of the Escherichia coli release factor-2 frameshift site weakened by a particularly poor context?

Authors:  L L Major; E S Poole; M E Dalphin; S A Mannering; W P Tate
Journal:  Nucleic Acids Res       Date:  1996-07-15       Impact factor: 16.971

5.  The close proximity of Escherichia coli genes: consequences for stop codon and synonymous codon use.

Authors:  A Eyre-Walker
Journal:  J Mol Evol       Date:  1996-02       Impact factor: 2.395

Review 6.  Posttranscriptional control of gene expression in yeast.

Authors:  J E McCarthy
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

7.  5' contexts of Escherichia coli and human termination codons are similar.

Authors:  A L Arkov; S V Korolev; L L Kisselev
Journal:  Nucleic Acids Res       Date:  1995-11-25       Impact factor: 16.971

8.  Connection between stop codon reassignment and frequent use of shifty stop frameshifting.

Authors:  Haritha Vallabhaneni; Hua Fan-Minogue; David M Bedwell; Philip J Farabaugh
Journal:  RNA       Date:  2009-03-27       Impact factor: 4.942

9.  Structure of the C-terminal end of the nascent peptide influences translation termination.

Authors:  A Björnsson; S Mottagui-Tabar; L A Isaksson
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

10.  The identity of the base following the stop codon determines the efficiency of in vivo translational termination in Escherichia coli.

Authors:  E S Poole; C M Brown; W P Tate
Journal:  EMBO J       Date:  1995-01-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.